Data from Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models
Authors:
- Katelyn F. HandleyKHKatelyn F. Handley
- Cristian Rodriguez-AguayoCristian Rodriguez-Aguayo
- Shaolin MaSMShaolin Ma
- Elaine SturESElaine Stur
- Robiya JosephRJRobiya Joseph
- Emine BayraktarEBEmine Bayraktar
- Santosh K. DasariSDSantosh K. Dasari
- Nghi NguyenNNNghi Nguyen
- Reid T. PowellRPReid T. Powell
- Mary SobieskiMSMary Sobieski
- Cristina IvanCICristina Ivan
- Mark KimMKMark Kim
Open Access
- 3 April 2023
- other
- Published by American Association for Cancer Research (AACR)